These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 26055920)

  • 61. Harmonizing Norwegian registries onto OMOP common data model: Mapping challenges and opportunities for pregnancy and COVID-19 research.
    Trinh NT; Houghtaling J; Bernal FL; Hayati S; Maglanoc LA; Lupattelli A; Halvorsen L; Nordeng HM
    Int J Med Inform; 2024 Nov; 191():105602. PubMed ID: 39153282
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comment on 'empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership'.
    Gagne JJ; Schneeweiss S
    Stat Med; 2013 Mar; 32(6):1073-4. PubMed ID: 23413214
    [No Abstract]   [Full Text] [Related]  

  • 63. Continuous versus group sequential analysis for post-market drug and vaccine safety surveillance.
    Silva IR; Kulldorff M
    Biometrics; 2015 Sep; 71(3):851-8. PubMed ID: 26011024
    [TBL] [Abstract][Full Text] [Related]  

  • 64. European Health Data & Evidence Network-learnings from building out a standardized international health data network.
    Voss EA; Blacketer C; van Sandijk S; Moinat M; Kallfelz M; van Speybroeck M; Prieto-Alhambra D; Schuemie MJ; Rijnbeek PR
    J Am Med Inform Assoc; 2023 Dec; 31(1):209-219. PubMed ID: 37952118
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Enhancing healthcare process analysis through object-centric process mining: Transforming OMOP common data models into object-centric event logs.
    Park G; Lee Y; Cho M
    J Biomed Inform; 2024 Aug; 156():104682. PubMed ID: 38944260
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Feasibility of Applying the OMOP Common Data Model to Traditional Eastern Asian Medicine Dataset.
    Cha J; Ahn EK; Yoon YH; Park MY
    Stud Health Technol Inform; 2024 Jan; 310():1349-1351. PubMed ID: 38270038
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Identifying appropriate reference data models for comparative effectiveness research (CER) studies based on data from clinical information systems.
    Ogunyemi OI; Meeker D; Kim HE; Ashish N; Farzaneh S; Boxwala A
    Med Care; 2013 Aug; 51(8 Suppl 3):S45-52. PubMed ID: 23774519
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The Food and Drug Administration's Post-Licensure Rapid Immunization Safety Monitoring program: strengthening the federal vaccine safety enterprise.
    Nguyen M; Ball R; Midthun K; Lieu TA
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():291-7. PubMed ID: 22262619
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Useful Interplay Between Spontaneous ADR Reports and Electronic Healthcare Records in Signal Detection.
    Pacurariu AC; Straus SM; Trifirò G; Schuemie MJ; Gini R; Herings R; Mazzaglia G; Picelli G; Scotti L; Pedersen L; Arlett P; van der Lei J; Sturkenboom MC; Coloma PM
    Drug Saf; 2015 Dec; 38(12):1201-10. PubMed ID: 26370104
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A vaccine study design selection framework for the postlicensure rapid immunization safety monitoring program.
    Baker MA; Lieu TA; Li L; Hua W; Qiang Y; Kawai AT; Fireman BH; Martin DB; Nguyen MD
    Am J Epidemiol; 2015 Apr; 181(8):608-18. PubMed ID: 25769306
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Detecting adverse drug reactions following long-term exposure in longitudinal observational data: The exposure-adjusted self-controlled case series.
    Schuemie MJ; Trifirò G; Coloma PM; Ryan PB; Madigan D
    Stat Methods Med Res; 2016 Dec; 25(6):2577-2592. PubMed ID: 24685766
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Conversion and Data Quality Assessment of Electronic Health Record Data at a Korean Tertiary Teaching Hospital to a Common Data Model for Distributed Network Research.
    Yoon D; Ahn EK; Park MY; Cho SY; Ryan P; Schuemie MJ; Shin D; Park H; Park RW
    Healthc Inform Res; 2016 Jan; 22(1):54-8. PubMed ID: 26893951
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Design considerations in an active medical product safety monitoring system.
    Gagne JJ; Fireman B; Ryan PB; Maclure M; Gerhard T; Toh S; Rassen JA; Nelson JC; Schneeweiss S
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():32-40. PubMed ID: 22262591
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Structured assessment for prospective identification of safety signals in electronic medical records: evaluation in the health improvement network.
    Cederholm S; Hill G; Asiimwe A; Bate A; Bhayat F; Persson Brobert G; Bergvall T; Ansell D; Star K; Norén GN
    Drug Saf; 2015 Jan; 38(1):87-100. PubMed ID: 25539877
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A comparison of the empirical performance of methods for a risk identification system.
    Ryan PB; Stang PE; Overhage JM; Suchard MA; Hartzema AG; DuMouchel W; Reich CG; Schuemie MJ; Madigan D
    Drug Saf; 2013 Oct; 36 Suppl 1():S143-58. PubMed ID: 24166231
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership.
    Stang PE; Ryan PB; Racoosin JA; Overhage JM; Hartzema AG; Reich C; Welebob E; Scarnecchia T; Woodcock J
    Ann Intern Med; 2010 Nov; 153(9):600-6. PubMed ID: 21041580
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Methods for observational post-licensure medical product safety surveillance.
    Nelson JC; Cook AJ; Yu O; Zhao S; Jackson LA; Psaty BM
    Stat Methods Med Res; 2015 Apr; 24(2):177-93. PubMed ID: 22138688
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Transparency, reproducibility, and replicability of pharmacoepidemiology studies in a distributed network environment.
    Rai A; Maro JC; Dutcher S; Bright P; Toh S
    Pharmacoepidemiol Drug Saf; 2024 Jun; 33(6):e5820. PubMed ID: 38783407
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A policy framework for public health uses of electronic health data.
    McGraw D; Rosati K; Evans B
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():18-22. PubMed ID: 22262589
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A novel algorithm for detection of adverse drug reaction signals using a hospital electronic medical record database.
    Park MY; Yoon D; Lee K; Kang SY; Park I; Lee SH; Kim W; Kam HJ; Lee YH; Kim JH; Park RW
    Pharmacoepidemiol Drug Saf; 2011 Jun; 20(6):598-607. PubMed ID: 21472818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.